TNF-Alpha Inhibition for Treatment of Alzheimer's Disease

NCT00203320 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: etanercept given by perispinal administration

Sponsor

Tobinick, Edward Lewis, M.D.